<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>2024-Q1 on FinStatInsight.com</title>
    <link>http://localhost:1313/tags/2024-q1/</link>
    <description>Recent content in 2024-Q1 on FinStatInsight.com</description>
    <generator>Hugo</generator>
    <language>en-us</language>
    <lastBuildDate>Wed, 29 May 2024 10:01:35 +0300</lastBuildDate>
    <atom:link href="http://localhost:1313/tags/2024-q1/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Southern Cable Group Berhad Q1 2024 Profit Surge To 18.57 Million</title>
      <link>http://localhost:1313/posts/southern-cable-group-berhad-1st-qtr-2024-profit-surge-18m/</link>
      <pubDate>Wed, 29 May 2024 10:01:35 +0300</pubDate>
      <guid>http://localhost:1313/posts/southern-cable-group-berhad-1st-qtr-2024-profit-surge-18m/</guid>
      <description>&lt;h3 id=&#34;southern-cable-group-berhad-q1-2024-summary&#34;&gt;Southern Cable Group Berhad Q1-2024 Summary&lt;/h3&gt;&#xA;&lt;p&gt;In the quarter ending March 31, 2024, the Group&amp;rsquo;s revenue rose to RM312.03 million, up from RM240.93 million in the same quarter last year, marking a 29.51% increase.&lt;/p&gt;&#xA;&lt;p&gt;The Malaysian market was the primary revenue source, contributing 98.65% of total revenue, while international sales made up the remaining 1.35%. Sales in Malaysia grew by 35.54%, while overseas sales dropped by 69.50% compared to the previous year.&lt;/p&gt;</description>
    </item>
    <item>
      <title>Jati Tinggi Group Berhad Q1 2024 Recorded 24.94% Net Profit Margin</title>
      <link>http://localhost:1313/posts/jati-tinggi-group-berhad-q1-2024-net-profit-margin-up/</link>
      <pubDate>Fri, 26 Apr 2024 10:01:35 +0300</pubDate>
      <guid>http://localhost:1313/posts/jati-tinggi-group-berhad-q1-2024-net-profit-margin-up/</guid>
      <description>&lt;h3 id=&#34;jati-tinggi-group-berhad-q1-2024-summary&#34;&gt;Jati Tinggi Group Berhad Q1-2024 Summary&lt;/h3&gt;&#xA;&lt;p&gt;In the quarter ending February 29, 2024, the Group&amp;rsquo;s revenue decrease to RM29.01 million, down from RM35.99 million in the preceding quarter ended November 30, 2024. The revenue decline aligns with the construction activities and progress of the Groupâ€™s ongoing projects as below:&lt;/p&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;The Danga Bay Project (double circuit underground cable installation from Danga Bay substation to Perling substation, Johor) contributed RM0.86 million in the current quarter, down from RM4.94 million in the preceding quarter.&lt;/li&gt;&#xA;&lt;li&gt;The installation, testing, and commissioning of 33kV underground cables and accessories from Keteri South substation to Chuping Valley Industrial Area (CVIA) substation, Perlis, generated RM1.82 million in the current quarter, compared to RM2.24 million in the preceding quarter.&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;p&gt;But, despite the revenue drop, the Group registered higher profit before taxation (RM8.18 million) and profit after taxation (RM7.24 million) for the first quarter ended 29 February 2024, which represent 24.94% net profit margin, primarily due to the gain of RM 7.24 million &lt;strong&gt;disposal of investment property&lt;/strong&gt;.&lt;/p&gt;</description>
    </item>
    <item>
      <title>Cengild Medical Berhad Q1 2024 Revenue 11% Growth vs Preceding Quarter.</title>
      <link>http://localhost:1313/posts/cengild-medical-berhad-q1-2024-revenue-growth-vs-preceding-quarter/</link>
      <pubDate>Thu, 30 Nov 2023 15:01:35 +0300</pubDate>
      <guid>http://localhost:1313/posts/cengild-medical-berhad-q1-2024-revenue-growth-vs-preceding-quarter/</guid>
      <description>&lt;h3 id=&#34;cengild-medical-berhad-q1-2024-summary&#34;&gt;Cengild Medical Berhad Q1-2024 Summary&lt;/h3&gt;&#xA;&lt;p&gt;In the current quarter Q1-2024 concluding on September 30, 2023, &lt;strong&gt;Cengild Medical Berhad&lt;/strong&gt; achieved a revenue of RM17.60 million. This marks a notable growth of RM1.83 million, equivalent to &lt;strong&gt;11.62%&lt;/strong&gt;, when juxtaposed with the preceding quarter concluding on June 30, 2023, which reported revenue of RM15.77 million. The upswing in revenue can be primarily attributed to the heightened volume of patients, leading to an augmentation in both endoscopic procedures and surgeries conducted.&lt;/p&gt;</description>
    </item>
  </channel>
</rss>
